An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.

NCT03433924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 248

Last updated 2024-03-27

No results posted yet for this study

Summary

The Primary Objective of this observational study is to investigate the prevalence of high PD-L1 expression in Chinese MIUBC patients.

Conditions

  • Urinary Bladder Cancer

Sponsors & Collaborators

Principal Investigators

  • Liqun ZHOU, doctor · Peking University First Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-18
Primary Completion
2023-03-27
Completion
2023-03-27

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03433924 on ClinicalTrials.gov